Dtsch Med Wochenschr 2009; 134(45): 2278-2282
DOI: 10.1055/s-0029-1241939
Übersicht | Review article
Hypertensiologie
© Georg Thieme Verlag KG Stuttgart · New York

Baroreflexstimulation bei therapierefraktärer arterieller Hypertonie

Baroreflex stimulation for resistant arterial hypertensionS. Eckert1 , B. Hansky2 , D. Horstkotte1
  • 1Kardiologische Klinik, Herz und Diabeteszentrum, Universitätsklinik der Ruhr-Universität Bochum
  • 2Klinik für Thorax- und Kardiovaskularchirurgie, Herz und Diabeteszentrum, Universitätsklinik der Ruhr-Universität Bochum
Further Information

Publication History

eingereicht: 1.7.2009

akzeptiert: 16.10.2009

Publication Date:
29 October 2009 (online)

Literatur

  • 1 Bisognamo J, De Leeuw P, Bach D S. et al . Improved cardiac structure and function in early-stage heart failure with chronic treatment using an implantable Device: Results from the European and United States Trials of the Rheos system.  J Cardiac Failure. 2008;  14 S48
  • 2 Bisognamo J, De Leeuw P, Irwin E. et al . Long term baroreflex hypertension therapy significantly lowers ambulatory blood pressure in patients with resistant hypertension.  Clin Hypertens. 2008;  10 A117
  • 3 Calhoun D, Jones D, Textor S. et al . Resistant hypertension: diagnosis, evaluation, and treatment: a sientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.  Hypertension. 2008;  51 1403-1419
  • 4 Chusid J G. Funktionelle Neurologie. Berlin, Heidelberg, New York; Springer Verlag 1978: 109-15
  • 5 De Leeuw P, Bisognamo J, Bach D S. et al . Deviced-based reduction in blood pressure is associated with increased diameter of the left ventricular outflow tract: Results from the European and United States Trials of the Rheos( System.  Circulation. 2008;  118 S887
  • 6 De Leeuw P, Bisognamo J, Bach D S. et al . Improved cardiac structure and diastolic flow velocities in early-stage heart failure with chronic treatment using an implantable Device: Results from the European and United States Trials of the Rheos( System.  J Am Coll Cardiol. 2009;  53 A188
  • 7 De Leeuw P, Gangahar D, Bach D S. et al . Left ventricular reverse remodeling with chronic treatment using an implantable device: Results from the European and United States trials of the Rheos( Baroreflex Hypertension Therapy System.  J Hypertens. 2008;  26 (Suppl 1) S471
  • 8 De Leeuw P, Kroon A A, Scheffers I. et al . Baroreflex hypertension therapy with a chronically implanted system: Preliminary efficicay and safety results from the Rheos DEBuT-HT study in patients with resistant hypertension.  J Hypertens. 2006;  24 (Suppl. 4) S300-S3001
  • 9 Green A L, Wang S, Owen S L. et al . Stimulating the human midbrain to reveal the link between pain and blood pressure.  Pain. 2006;  124 349-59
  • 10 Griffith L CS, Schwartz S I. Electrical stimulation of the carotid sinus nerve in normotensive and renal hypertensive dogs.  Circulation. 1963;  28 730
  • 11 Hamberger C A, Carlsten A, Folkow B. et al . Some cardiovascular observation during radical neck dissection.  Cancer. 1957;  10 938-43
  • 12 Heusser K, Tank  J, Diedrich A. et al . Electrical carotid sinus stimulation reduces symphatetic activity and blood pressure in patients with refractory hypertension.  J Hypertens. 2009;  27 (Suppl 1) S 288
  • 13 Lohmeier T E, Dwyer T M, Hildebrandt D A. et al . Suppression of the renin-angiotensin system contributes by prolonged baroreflex activation.  Hypertension. 2004;  44 500
  • 14 Lohmeier T E, Irwin E D, Rossing M A. et al . Prolonged activation of the baroreflex produces sustainede hypotension.  Hypertension. 2004;  43 306-11
  • 15 Mancia G, De Backer G, Dominczak A. et al . Guidelines for the mangagement of arterial hypertension: The Task Force for the Mangement of Arterial Hypertension of the European Society of Hypertesnion (ESH) and of the European Society of Cardiology (ESC).  Eur Heart J. 2207;  28 1462-1536
  • 16 Mc Gubbin J W, Green J H, Page I H. Baroreceptor function in chronic renal hypertension.  Circ Res. 1956;  4 2560-72
  • 17 Middeke M. Hypertensiologie 2007.  Dtsch Med Wochenschr. 2007;  132 1368-1370
  • 18 Middeke M. Hypertensiologie 2009.  Dtsch Med Wochenschr. 2009;  142 1312-15
  • 19 National Institutes of Health .Device Based Therapy in Hypertension Extension Trial (DEBuT-HET). Available at: http://clinicaltrials.gov/ct2/show/NTC00710294. 
  • 20 Wolf-Maier K, Cooper R. et al . Hypertension prevalance and blood pressure levels in 6 European Countries; Canada, and the United States.  J Am Med Assoc. 2003;  289 2363-69
  • 21 Rosamond W, Flegal K, Furie K. et al . Heart disease and stroke statistics 2008 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee.  Circulation. 2008;  117 76-80
  • 22 Rothstein M, De Leeuw P, Elletson M. et al .Chronic treatment of resistant hypertension with an implantable device: interim 2 year results of two studies of the Rheos( Hypertension System. Late-Breakiong Clinical Trials III: Emerging Technologies Session 407 ACC,. Orlando; March 30th, 2009
  • 23 Schmidli S, Savolainen H, Eckstein F. et al . Acute device-based blood pressure reduction: Electrcal activation of the carotid baroreflex in patients undergoing elective carotid surgery.  Vascular. 2007;  15 63-9
  • 24 Scheffers I, Schmidli J, Kroon A A. et al . Sustained blood pressure reduction by baroreflex hypertension therapy with a chronically implanted system: long-term data from the Rheos DEBuT-HT study in patient with resistant hypertension.  J Hypertens. 2007;  25 141-2
  • 25 Scheffers I JM, Schmidli J, Kroon A A. et al . Sustained blood pressure reduction by baroreflex hypertension therapy with a chronically implated system: 3-year data from the Rheos Debut-Ht Study in patients with resistent hypertension.  J Hypertens. 2209;  27 (Suppl 1) S421
  • 26 Scheffers I, Kroon A, De Leeuw P. Renal haemodynamics during chronic therapy with electrical stimulation of the carotid sinus in human.  J Hypertens. 2008;  28 (Suppl1) S465
  • 27 Schwartz P J. et al . Long term vagal stimulation in patients with advanced heart failure. First experience in man.  Eur J Heart Fail. 2008;  10 884-91
  • 28 Peters T K. Therapeutische Blutdrucksenkung durch ein aktives Implantat: Ein neues Verfahren zur Behandlung der medikamentös therapierefraktären Hypertonie.  J Hypert. 2008;  12 22-7
  • 29 Wustmann K, Kucera J P, Scheffers I. et al . Effects of chronic baroreflex stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension.  Hypertension. 2009;  54 530-6
  • 30 Zucker I H, Hackley J F, Cornisch K G. et al . Chronic baroreflex activation enhances survival in dogs with pacing-induced heart failure.  Hypertension. 2007;  50 1201-8
  • 31 Cameron T. Safety and efficacy of spinal cord stimulation for the treatment of chronic pain: a 20 year literature review.  J Neurosurg. 2004;  100 254-67
  • 32 Kumar K, Buchser E, Linderoth B. et al . Avoiding complication from spinal cord stimulation: practical recommendations from an international panel of experts.  Neuromodulation. 2007;  10 24-33

Dr. Siegfried Eckert

Kardiologische Klinik, Herz- und Diabeteszentrum Nordrhein-Westfalen, Klinik der Ruhr-Universität Bochum

Georgstraße 11

32545 Bad Oeynhausen

Phone: 05731/970

Fax: 05731/971874

Email: seckert@hdz-nrw.de

    >